Three independent discounted-cash-flow-style models value Gilead Sciences, Inc. every trading day. 1 of 3 currently price GILD above its market price.
| Free Cash Flow model | $161.92 |
| Excess Profit model | $124.13 |
| Residual Earnings model | $55.15 |
| Dividend Discount model | $95.54 |
| Piotroski F-Score | 8 / 9 |
| Return on invested capital | +19.4% |
| Net debt / EBITDA | 1.2× |
| Gross margin | +78.8% |
| Revenue CAGR | +2.6% |
| Cash conversion | 1.2× |
| Dividend yield | +2.3% |
| Buyback yield | +0.4% |
These are StockKitty's default assumptions. In the app, the models recompute live as you adjust growth, discount rates, and margins — and the AI explains the bull case, bear case, and quality picture.
Open GILD in StockKitty